National Institute for Health and Clinical Excellence (NICE)
NICE 20th Anniversary: Parliamentary Reception and Awards
NICE has hosted a parliamentary reception and awards ceremony in celebration of its 20th anniversary.
The event, held on Wednesday, June 12, in the Terrace Pavilion of the House of Commons at the Palace of Westminster, was a celebration of NICE’s success over the past 20 years and a look ahead to the future.
Around 200 invited guests came from a broad range of national and local organisations along with individuals and parliamentarians who work alongside NICE and take a real interest in the work the institute does, including Royal Colleges, patient groups, industry bodies and academic institutions.
During the evening the Distinguished Contribution to NICE Awards were presented by NICE’s chair Sir David Haslam to 20 individuals who have made an outstanding contribution to the organisation since it was established in 1999.
List of award winners:
Professor Sir Michael Rawlins - Founding chair of NICE, from 1999 to 2013. He led the organisation in its formative years and through the evolution of its main programmes.
Mercy Jeyasingham MBE – A non-executive director of the NICE board from 2001 to 2013. Mercy made an important contribution to the early development and governance of NICE.
Professor Anthony Culyer CBE – Played an influential role in the development of NICE, through his work as a non-executive director.
Professor Catherine Law CBE – Inaugural chair of NICE's public health interventions advisory committee from 2005 to 2015. Helped to establish the credibility of NICE’s public health programme among public health professionals.
Professor David Barnett – Inaugural chair of the first appraisal committee for ten years, making a formative contribution to the development of NICE’s methods and processes.
Jean Gaffin OBE – An inaugural member of NICE’s appraisal committee. Her advocacy for patients and those who speak for them had a formative influence on NICE’s appraisal methods.
Professor Bruce Campbell – Chaired both the interventional procedures and the medical technologies advisory committees between 2002 and 2015 and was instrumental in developing their methods and processes.
Dr Tessa Lewis – Chaired several NICE advisory committees, including, since 2016, the managing common infections advisory committee, the quality standards advisory committee from 2012 and the indicators advisory committee since 2015.
Professor Andrew Stevens – The longest-serving committee member and chair before stepping down in 2017, Andrew played a formative role in the development of the technology appraisal programme.
Dr Jane Adam – Chair and member of NICE’s appraisal committees since 2009.
Andrew McKeon – Andy spent eight years as a non-executive director and then deputy chair of the NICE Board.
Professor Rona McCandlish – Former non-executive director of NICE from 2007 to 2016, Rona made a significant contribution to the development of the guidelines programme.
Patrick Storrie – Since the introduction of NICE’s external appeal panel, Paddy has served the panel with distinction, chairing eight appeals and acting as a lay member for another two.
Dr Amanda Adler – A member of one of NICE’s appraisal committees since 2006 and chair since 2009, Amanda has contributed to the development of NICE’s technology appraisal methods and processes.
Professor Stephen Pilling – As co-director of the former Mental Health Guidelines Collaborating Centre and chair of several NICE clinical guideline committees, Steve Pilling has made a significant contribution to NICE's guidelines methods and its mental health guidance.
Bridget Warr CBE – As chair of two NICE social care guideline development groups and member of a quality standard group, Bridget Warr has helped to shape the development of NICE's guidelines for the social care sector.
Dr Margaret Helliwell – A former non-executive director of NICE and subsequently vice chair of the board, between 2007 and 2015, Maggie made a significant contribution to the governance of the institute.
Julia Earnshaw – Led GlaxoSmithKline’s engagement with NICE. Julia influenced the development of NICE’s methods and helped to create a positive relationship between the life sciences industry and NICE.
Professor Martin Eccles – Founding chair of the guidelines advisory committee and instrumental in designing NICE’s approach to guideline development. He was also chair of the implementation strategy group and has been a mentor for our fellows and scholars programme.
Professor Sir David Haslam – Founding chair of NICE's accreditation advisory committee and has been chair of the NICE Board since 2013, leading the organisation with distinction through a period of significant external change.
NICE would like to thank all who attended and thank those who received awards for their fantastic contribution to the institute over the past 20 years.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
Wireless device recommended for treating people with overactive bladder14/02/2020 12:15:00
Axonics SNS has potential to save the NHS around £6,200 per patient if the device lasts more than six years
Researchers wanted to study the public’s views of health-related quality of life13/02/2020 11:15:00
Researchers have been asked to express their interest in running a study of the UK public’s valuation of health-related quality of life.
Appeal panel rules that NICE needs to request evidence for erenumab effectiveness in subgroup of people with chronic migraine05/02/2020 14:15:00
NICE yesterday (4 February 2020) published the outcome of the appeal against its final draft guidance (FAD) on erenumab (also called Aimovig and made by Novartis) for preventing chronic migraine.
Broader types of data to be used in development of NICE guidance04/02/2020 16:15:00
An expanded evidence base could allow NICE to address evidence gaps and enhance reviews of the impact of our guidance.
NICE publishes updated principles31/01/2020 15:25:00
NICE has published a simple guide to the way we develop our guidance and standards.
Nasal spray medicine for treatment-resistant depression not recommended by NICE29/01/2020 11:15:00
More evidence on the clinical and cost effectiveness of esketamine needed.
Digital and mobile interventions could support regular health services in helping people stop smoking and reduce their risk of obesity, says NICE24/01/2020 11:15:00
Health professionals can consider digital and mobile interventions as a supplement to regular services to support behaviour change in people at risk of developing chronic conditions.
Care matters – Working together to get support right for adult carers23/01/2020 11:15:00
Dame Philippa Russell, Vice-President of Carers UK and Topic Adviser for the NICE guideline on Supporting Adult Carers.
NICE encourages further data collection on ‘game changing’ histology independent cancer drugs17/01/2020 14:10:00
Larotrectinib (also called Vitrakvi and made by Bayer), a new treatment for a range of cancers, can’t be recommended for use in the NHS because at its current price, it doesn’t have the potential to be cost-effective.